ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Delphx Capital Markets Inc

Delphx Capital Markets Inc (DELX)

0.14
0.00
(0.00%)
Closed 05 January 8:00AM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
0.14
Bid
0.13
Offer
0.135
Volume
2,000
0.14 Day's Range 0.14
0.055 52 Week Range 0.20
Market Cap
Previous Close
0.14
Open
0.14
Last Trade
2000
@
0.14
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
29,991
Shares Outstanding
150,755,000
Dividend Yield
-
PE Ratio
-10.29
Earnings Per Share (EPS)
-0.01
Revenue
-
Net Profit
-2.04M

About Delphx Capital Markets Inc

Sector
Misc Personal Services, Nec
Industry
Unit Inv Tr, Closed-end Mgmt
Website
Headquarters
Toronto, Ontario, Can
Founded
2018
Delphx Capital Markets Inc is listed in the Misc Personal Services sector of the TSX Venture Exchange with ticker DELX. The last closing price for Delphx Capital Markets was $0.14. Over the last year, Delphx Capital Markets shares have traded in a share price range of $ 0.055 to $ 0.20.

Delphx Capital Markets currently has 150,755,000 shares in issue. The market capitalisation of Delphx Capital Markets is $21.11 million. Delphx Capital Markets has a price to earnings ratio (PE ratio) of -10.29.

DELX Latest News

DelphX Completes First CPO and CRN Issuance; Introduces Revolutionary Yield and Risk Tools for the Global Bond Market

DelphX Completes First CPO and CRN Issuance; Introduces Revolutionary Yield and Risk Tools for the Global Bond Market Canada NewsWire TORONTO, June 9, 2022 TORONTO, June 9, 2022 /CNW/ - DelphX...

L'OCRCVM permet la reprise de la négociation - DELX

L'OCRCVM permet la reprise de la négociation - DELX Canada NewsWire VANCOUVER, BC, le 22 mars 2022 VANCOUVER, BC, le 22 mars 2022 /CNW/ - Reprise des négociations pour : Société :...

IIROC Trading Resumption - DELX

IIROC Trading Resumption - DELX Canada NewsWire VANCOUVER, BC, March 22, 2022 VANCOUVER, BC, March 22, 2022 /CNW/ - Trading resumes in: Company: DelphX Capital Markets Inc. TSX-Venture Symbol:...

Suspension de la négociation par l'OCRCVM - DELX

Suspension de la négociation par l'OCRCVM - DELX Canada NewsWire VANCOUVER, BC, le 21 mars 2022 VANCOUVER, BC, le 21 mars 2022 /CNW/ - L'OCRCVM a suspendu la négociation des titres...

IIROC Trading Halt - DELX

IIROC Trading Halt - DELX Canada NewsWire VANCOUVER, BC, March 21, 2022 VANCOUVER, BC, March 21, 2022 /CNW/ - The following issues have been halted by IIROC: Company: DelphX Capital Markets...

DelphX Announces Non-Brokered, Unit Financing

DelphX Announces Non-Brokered, Unit Financing Canada NewsWire TORONTO, March 12, 2020 /NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ TORONTO, March...

DelphX Announces the Issuance of Options

DelphX Announces the Issuance of Options Canada NewsWire TORONTO, Dec. 10, 2019 TORONTO, Dec. 10, 2019 /CNW/ - DelphX Capital Markets Inc. (TSXV: DELX) ("DelphX") announced that the...

DelphX Announces the Issuance of Options

DelphX Announces the Issuance of Options Canada NewsWire TORONTO, Nov. 5, 2019 TORONTO, Nov. 5, 2019 /CNW/ - DelphX Capital Markets Inc. (TSXV: DELX) ("DelphX") announced that the Board...

DelphX Closes Previously Announced Unit and Debenture Financings

DelphX Closes Previously Announced Unit and Debenture Financings Canada NewsWire TORONTO, Sept. 4, 2019 /NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/...

DelphX Grants Stock Options

DelphX Grants Stock Options Canada NewsWire TORONTO, July 9, 2019 TORONTO, July 9, 2019 /CNW/ - DelphX Capital Markets Inc. (TSXV: DELX) ("DelphX") announced that the Board of Directors...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.015120.1250.1550.1251786930.13098854CS
40.017.692307692310.130.1550.11541200.13076311CS
12-0.01-6.666666666670.150.1550.1299910.12617724CS
260.04547.36842105260.0950.20.08295860.13343076CS
52-0.03-17.64705882350.170.20.055394430.12173356CS
156-0.32-69.56521739130.460.540.055564650.17816805CS
260-0.01-6.666666666670.150.880.04543170.22713084CS

DELX - Frequently Asked Questions (FAQ)

What is the current Delphx Capital Markets share price?
The current share price of Delphx Capital Markets is $ 0.14
How many Delphx Capital Markets shares are in issue?
Delphx Capital Markets has 150,755,000 shares in issue
What is the market cap of Delphx Capital Markets?
The market capitalisation of Delphx Capital Markets is CAD 21.11M
What is the 1 year trading range for Delphx Capital Markets share price?
Delphx Capital Markets has traded in the range of $ 0.055 to $ 0.20 during the past year
What is the PE ratio of Delphx Capital Markets?
The price to earnings ratio of Delphx Capital Markets is -10.29
What is the reporting currency for Delphx Capital Markets?
Delphx Capital Markets reports financial results in CAD
What is the latest annual profit for Delphx Capital Markets?
The latest annual profit of Delphx Capital Markets is CAD -2.04M
What is the registered address of Delphx Capital Markets?
The registered address for Delphx Capital Markets is 15 PRINCE ARTHUR STREET, TORONTO, ONTARIO, M5R 1B2
What is the Delphx Capital Markets website address?
The website address for Delphx Capital Markets is www.delphx.com
Which industry sector does Delphx Capital Markets operate in?
Delphx Capital Markets operates in the UNIT INV TR, CLOSED-END MGMT sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MUST.HMust Capital Inc
$ 0.06
(200.00%)
165k
KUAI.PKua Investments Inc
$ 0.045
(125.00%)
14k
CRBKCarebook Technologies Inc
$ 0.095
(111.11%)
420.1k
CPLCopper Lake Resources Ltd
$ 0.01
(100.00%)
9k
VKG.HNorse Gold Corp
$ 0.02
(100.00%)
2.16k
TVITVI Pacific Inc
$ 0.005
(-50.00%)
11k
MTBMTB Metals Corp
$ 0.01
(-50.00%)
116.4k
ETUE2gold Inc
$ 0.005
(-50.00%)
10k
KOVOKovo+ Holdings Inc
$ 0.035
(-41.67%)
15k
PORPortofino Resources Inc
$ 0.01
(-33.33%)
349k
MATEBlockmate Ventures Inc
$ 0.41
(38.98%)
9.03M
DMDataMetrex AI Limited
$ 0.005
(0.00%)
4.48M
THRMTherma Bright Inc
$ 0.04
(14.29%)
3.45M
GPUSAlset AI Ventures Inc
$ 0.16
(-3.03%)
2.41M
SSESilver Spruce Resources Inc
$ 0.005
(0.00%)
2.14M

Discussion

View Full Feed
Mr. Bill Mr. Bill 8 minutes ago
https://www.medicinenet.com/what_are_blood_oxygen_levels/article.htm
devil dog 96 devil dog 96 9 minutes ago
Tell everyone why you think they never took the 39 million shares off restriction if they need shares to dump? Why have they not taken 1 share off restriction since early 2021 if they need shares to dump?? Why would they issue new shares that will be unregistered and also have to wait a year before
ATMH
CrossFireTrader CrossFireTrader 9 minutes ago
Page 22 of 26, and If say I'm Bullish that'll set 280e off, and I'll  be accused of pumping our little lottery ticket. I'm here for the long haul. I'm not here to sell at 0.016 or 0.02 or 0.03 or whatever his new price is. He actually likes GDVM a lot more than he lets on. Since you seem to be somew
GDVM
Mr. Bill Mr. Bill 13 minutes ago
https://measuringmyhealth.com/what-is-a-normal-pi-on-a-pulse-oximeter/
georgejjl georgejjl 13 minutes ago
That is WRONG. The current standard of care is donepezil (Aricept) and memantine, etc.

MAB's still are an extremely small number of treatments for Alzheimer's in the USA and worldwide.

Good luck and GOD bless,
AVXL
axelvento axelvento 33 minutes ago
Q1 the first interim analysis of the vaccine’s efficacy is expected

Moderna’s mRNA-1647
Cytomegalovirus
MRNA
MightyX MightyX 36 minutes ago
Yet no one is innocent
TPTW
BIG D 4 BIG D 4 37 minutes ago
WOW !! HAPPY NEW YEAR TO ALL THE LONGS HERE !! I HAVE 2 NAYSAYERS ON IGNORE SO I NEVER READ THEIR BS !! GO SAVING GRACE-- JJ AND ALL THE NEW POSTERS WHO ARE POSITIVE !! .02 CENTS TO START THE RUN TO ONE DOLLAR IS WHERE WE SHOULD BE !! THIS STOCK IS SUCH A GREAT BUY HERE !! I AM LOADED WITH 32 MILLI
MJNA
MightyX MightyX 37 minutes ago
The judicial system legitimizes prosecution
TPTW
jondoeuk jondoeuk 38 minutes ago
A new paper. From it: 'BNT221 was well tolerated across both DLs, with no dose-limiting toxicities of grade 3 or higher attributed to the T cell product observed. Specifically, no cytokine release, immune effector cell-associated neurotoxicity or macrophage activation syndromes were reported. A dose
BNTX
benz280c benz280c 39 minutes ago
Nice to see you are bullish. This quote may round out your knowledge.
"It is worthy to note that a new CUSIP has been approved by the CUSIP Global Services (CGS).
Subsequently, we have submitted a corporation action with FINRA for a Company name change, Ticker Symbol Change and Cusip
GDVM
shajandr shajandr 40 minutes ago
Sorry to read that you're still feeling sick. I posted a week or two ago about 41 bunnies and also some cats and dogs that were rescued from a home in Delaware county, Iowa and that were transferred to the DBQ county animal shelter. I just spoke with DaSqu_w and she went to the animal shelter to see
Lakota-45 Lakota-45 41 minutes ago
Will do, but I doubt they will listen !!!

~ Lol !!!
IONI
boi568 boi568 42 minutes ago
Probably
AVXL
HokieHead HokieHead 44 minutes ago
Wrong..
TWOH
HokieHead HokieHead 45 minutes ago
Get your facts straight, the halt was in the Canadian side as they are reviewing all the disclosures submitted, there’s ZERO issues in the US, it’s a fully reporting SEC company.
TWOH
Lakota-45 Lakota-45 46 minutes ago
I agree with you 'farmI1234 !!!

I'm pretty sure most of the Savvy Investors, that have been paying attention,
have been loading the dips, and .0004's, for a while now.
I know I have, along with fishing down stream.

I doubt any Longs will get caught short,
WDLF
CaptHowdy CaptHowdy 48 minutes ago
RECOMMENDED.... nothing is offical yet, unnecessary twisting of facts to bolster your negative viewpoints. Thats news is two months old
GRLT
axelvento axelvento 48 minutes ago
Cancer vaccines: What’s ahead in 2025

The spotlight is on mRNA-4157 (V940)

https://gulfnews.com/special-reports/cancer-vaccines-whats-ahead-in-2025-1.500010233
MRNA
facts_matter14 facts_matter14 49 minutes ago
Does this sound like a company with 16 products and a 17th on the way?

https://investorshub.advfn.com/uimage/uploads/2024/12/24/mwowsIMG_6034.png








.
SRMX
HomerRomer HomerRomer 49 minutes ago
More testimony videos from trial participants like the Australian news reel of Ern Heaven would be amazing. I would think that most of the people involved 9 years ago in the earlier phase studies have passed on since the average life expectancy is normally between 3-11 years after being diagnosed w
AVXL
CaptHowdy CaptHowdy 50 minutes ago
That's how to make money on the OTC. 🤦🏻‍♂️ Anyone could do it; only if the effort spent discounting the new leadership in place along with the turn around story underway was used to turn a profit vs. using 9yr old DD to bad mouth new CEO.
GRLT
crescentmotor crescentmotor 51 minutes ago
I think that is a bad precedent to start.

100% on parading a handful of Blarcamesine patients at the JPM conference. I highly doubt AVXL would involve itself with anecdotal gimmicks where there is no way possible to extrapolate isolated successes to meaningful conclusions about broad
AVXL JPM

Your Recent History

Delayed Upgrade Clock